Amgen news

Heart drug pipeline

Drugmakers eye Lp(a) as next big test in heart medicine

Novartis, Amgen and Eli Lilly are in late-stage trials to see whether sharply lowering a genetic cholesterol risk can prevent heart attacks

Apr 28, 2026